P.F. Zangerle

917 total citations
16 papers, 810 citations indexed

About

P.F. Zangerle is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P.F. Zangerle has authored 16 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P.F. Zangerle's work include Cancer Cells and Metastasis (4 papers), Cancer Genomics and Diagnostics (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). P.F. Zangerle is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Cancer Genomics and Diagnostics (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). P.F. Zangerle collaborates with scholars based in Belgium, France and United States. P.F. Zangerle's co-authors include P Franchimont, M. Lopez, D De Groote, I. Dehart, R. Gathy, M. Baudrihaye, Yves Béguin, Dominique L. Delacroix, Marie France Fassotte and Jacques Pirenne and has published in prestigious journals such as Cancer, Annals of the New York Academy of Sciences and Osteoporosis International.

In The Last Decade

P.F. Zangerle

14 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P.F. Zangerle Belgium	10	253	228	115	114	74	16	810
M. Lopez Belgium	10	305 1.2×	233 1.0×	124 1.1×	83 0.7×	92 1.2×	15	852
M. Baudrihaye France	6	464 1.8×	167 0.7×	170 1.5×	103 0.9×	77 1.0×	7	1.0k
I. Dehart Belgium	7	281 1.1×	126 0.6×	116 1.0×	49 0.4×	92 1.2×	10	689
A Mackiewicz United States	12	277 1.1×	336 1.5×	164 1.4×	139 1.2×	190 2.6×	21	1.2k
R. Gathy Belgium	8	244 1.0×	95 0.4×	110 1.0×	38 0.3×	75 1.0×	9	566
David Díaz Spain	19	204 0.8×	293 1.3×	366 3.2×	110 1.0×	66 0.9×	35	984
Luís Menchén Spain	20	223 0.9×	280 1.2×	406 3.5×	94 0.8×	87 1.2×	82	1.3k
Mohammad Reza Atashzar Iran	7	118 0.5×	237 1.0×	96 0.8×	166 1.5×	50 0.7×	16	782
D. Fuchs Austria	10	124 0.5×	210 0.9×	100 0.9×	29 0.3×	65 0.9×	14	701
Timothy P. Plackett United States	16	280 1.1×	157 0.7×	239 2.1×	50 0.4×	30 0.4×	56	954

Countries citing papers authored by P.F. Zangerle

Since Specialization

Citations

This map shows the geographic impact of P.F. Zangerle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.F. Zangerle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.F. Zangerle more than expected).

Fields of papers citing papers by P.F. Zangerle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.F. Zangerle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.F. Zangerle. The network helps show where P.F. Zangerle may publish in the future.

Co-authorship network of co-authors of P.F. Zangerle

This figure shows the co-authorship network connecting the top 25 collaborators of P.F. Zangerle. A scholar is included among the top collaborators of P.F. Zangerle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.F. Zangerle. P.F. Zangerle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Zangerle, P.F., et al.. (2015). Casein and Other Tumor Markers in Relation to Cancer of the Breast. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 22. 141–148.

Zheng, SX, Y Vrindts, M. Lopez, et al.. (1997). Increase in cytokine production (IL-1β, IL-6, TNF-α but not IFN-γ, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas. 26(1). 63–71. 126 indexed citations

Zheng, SX, Vincent Geenen, Y Vrindts, et al.. (1996). Increase in IL-1β, IL-6 and, TNF-α production in postmenopausal osteoporosis. Osteoporosis International. 6(S1). 101–101. 2 indexed citations

Groote, D De, P.F. Zangerle, Y. Gevaert, et al.. (1992). Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine. 4(3). 239–248. 433 indexed citations

Zangerle, P.F., Donat De Groote, M. Lopez, et al.. (1992). Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine. 4(6). 568–575. 102 indexed citations

Legros, J.J., Vincent Geenen, Henri Martens, et al.. (1990). Neurophysins as Markers of Vasopressin and Oxytocin Release. Hormone Research. 34(3-4). 151–155. 16 indexed citations

Zangerle, P.F., F. Spyratos, V Le Doussal, et al.. (1986). Breast Cyst Fluid Proteins and Breast Cancer^a. Annals of the New York Academy of Sciences. 464(1). 331–349. 13 indexed citations

Spyratos, F., V Le Doussal, P.F. Zangerle, & P Franchimont. (1986). Immunohistochemical Detection of Alpha‐Lactalbumin and Gross Cyst Fluid Protein in Human Breast Carcinoma. Annals of the New York Academy of Sciences. 464(1). 571–572. 2 indexed citations

Doussal, V Le, P.F. Zangerle, J. Collette, et al.. (1985). Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15,000. European Journal of Cancer and Clinical Oncology. 21(6). 715–725. 22 indexed citations

10.

Zangerle, P.F. & P Franchimont. (1985). Validation of radioimmunoassay for human lactalbumin in the serum by testing the endogenous antibodies interference. European Journal of Cancer and Clinical Oncology. 21(10). 1201–1208. 6 indexed citations

11.

Doussal, V Le, P.F. Zangerle, J. Collette, et al.. (1984). Immunohistochemical detection of alphalactalbumin in breast lesions. European Journal of Cancer and Clinical Oncology. 20(8). 1069–1078. 12 indexed citations

12.

Franchimont, P, et al.. (1981). Tumor Associated Markers in Breast Cancer. PubMed. Suppl 1. 255–265. 1 indexed citations

13.

Hendrick, J.C., P.F. Zangerle, & P Franchimont. (1979). Casein and Breast Cancer. Recent results in cancer research. 67. 39–44. 1 indexed citations

14.

Franchimont, P & P.F. Zangerle. (1977). Present and future clinical relevance of tumour markers. European Journal of Cancer (1965). 13(7). 637–646. 12 indexed citations

15.

Franchimont, P, et al.. (1977). Simultaneous assays of cancer associated antigens in benign and malignant breast diseases. Cancer. 39(6). 2806–2812. 22 indexed citations

16.

Franchimont, P, P.F. Zangerle, J Bury, et al.. (1976). Simultaneous assays of cancer-associated antigens in various neoplastic disorders. Cancer. 38(6). 2287–2295. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact